ATE98240T1 - Tetrahydropyridinyl substituierte tricyclische derivate mit dopamin antagonistischer wirkung. - Google Patents

Tetrahydropyridinyl substituierte tricyclische derivate mit dopamin antagonistischer wirkung.

Info

Publication number
ATE98240T1
ATE98240T1 AT91201688T AT91201688T ATE98240T1 AT E98240 T1 ATE98240 T1 AT E98240T1 AT 91201688 T AT91201688 T AT 91201688T AT 91201688 T AT91201688 T AT 91201688T AT E98240 T1 ATE98240 T1 AT E98240T1
Authority
AT
Austria
Prior art keywords
disorder
hydrogen
lower alkyl
antagonist action
dopamine antagonist
Prior art date
Application number
AT91201688T
Other languages
English (en)
Inventor
James Cairns
Samuel George Gibson
Duncan Robertson Rae
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Application granted granted Critical
Publication of ATE98240T1 publication Critical patent/ATE98240T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT91201688T 1990-07-24 1991-07-02 Tetrahydropyridinyl substituierte tricyclische derivate mit dopamin antagonistischer wirkung. ATE98240T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90308071 1990-07-24
EP91201688A EP0468562B1 (de) 1990-07-24 1991-07-02 Tetrahydropyridinyl substituierte tricyclische Derivate mit Dopamin antagonistischer Wirkung

Publications (1)

Publication Number Publication Date
ATE98240T1 true ATE98240T1 (de) 1993-12-15

Family

ID=8205498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91201688T ATE98240T1 (de) 1990-07-24 1991-07-02 Tetrahydropyridinyl substituierte tricyclische derivate mit dopamin antagonistischer wirkung.

Country Status (13)

Country Link
EP (1) EP0468562B1 (de)
JP (1) JPH04234384A (de)
KR (1) KR920002595A (de)
AT (1) ATE98240T1 (de)
AU (1) AU640799B2 (de)
CA (1) CA2046488A1 (de)
DE (1) DE69100741T2 (de)
ES (1) ES2062671T3 (de)
FI (1) FI913495A (de)
IE (1) IE912239A1 (de)
NZ (1) NZ239052A (de)
PT (1) PT98421A (de)
ZA (1) ZA915128B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013028999A1 (en) 2011-08-24 2013-02-28 The Trustees Of Columbia University In The City Of New York Small molecule inducers of gdnf as potential new therapeutics for neuropsychiatric disorders
US11840541B2 (en) 2014-11-26 2023-12-12 The Trustees Of Columbia University In The City Of New York Opioid receptor modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1184251A (en) * 1966-04-15 1970-03-11 American Cyanamid Co Oxazepines and Thiazepines
US4221714A (en) * 1979-08-03 1980-09-09 American Cyanamid Company 11-(1,2,3,6-Tetrahydro-substituted-4-pyridyl)-dibenz[b,f][1,4]oxazepines
US4798841A (en) * 1987-03-31 1989-01-17 Warner-Lambert Company Tetrahydropyridine oxime cholinergic agents and method of treatment
DE3726908A1 (de) * 1987-08-13 1989-02-23 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3735895A1 (de) * 1987-10-23 1989-05-03 Thomae Gmbh Dr K Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
JPH04234384A (ja) 1992-08-24
AU8038591A (en) 1992-01-30
FI913495A (fi) 1992-01-25
ZA915128B (en) 1992-05-27
IE912239A1 (en) 1992-01-29
EP0468562B1 (de) 1993-12-08
KR920002595A (ko) 1992-02-28
FI913495A0 (fi) 1991-07-19
DE69100741D1 (de) 1994-01-20
AU640799B2 (en) 1993-09-02
ES2062671T3 (es) 1994-12-16
NZ239052A (en) 1992-11-25
CA2046488A1 (en) 1992-01-25
PT98421A (pt) 1992-05-29
EP0468562A1 (de) 1992-01-29
DE69100741T2 (de) 1994-04-28

Similar Documents

Publication Publication Date Title
DK1026147T3 (da) Forbindelser, der er anvendelige som mellemprodukter i fremstillingen af piperidinderivater
DE69736642D1 (de) Heterocyclische Verbindungen, ihre Herstellung und Verwendung
DK0979821T3 (da) Tricykliske forbindelser
ATE124699T1 (de) Tricyclische carbapenemverbindungen.
PT733621E (pt) Novos derivados de imidazole e processo para a sua preparacao
DE69613710D1 (de) Benzoxazepinverbindungen, ihre herstellung und verwendung als lipidsenker
ATE346850T1 (de) 5-ht4-rezeptor-antagonisten
PE34996A1 (es) Nuevo derivado de pirrocarbazol
FI942294A (fi) Bentsopyraanijohdannaiset ja niiden käyttö
ATE98240T1 (de) Tetrahydropyridinyl substituierte tricyclische derivate mit dopamin antagonistischer wirkung.
DE69202594D1 (de) Zusammensetzung gegen Katarakt.
DE69624459T2 (de) Kondensierte indan-derivate und ihre salze
ES2063177T3 (es) Antagonistas de calcio.
ATE227286T1 (de) 2-carbonylthiazolderivate und ihre verwendung
NO920041L (no) Tetrahydropyridinyldibenzazepin-derivater
TW288015B (en) New chromene derivatives
DE68911893D1 (de) Antagonisten von Leukotrien D4.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee